Supera Stent for Peripheral Arterial Disease: Scoping Review with ☸️SAIMSARA.

Name: SAIMSARA Evidence Object vascular::SUPERA_STENT_SS
Creator: SAIMSARA
License: https://saimsara.com/license/

SAIMSARA

doi:10.62487/saimsara32125f88

SAIMSARA Journal

Machine-Readable Science • ISSN 3054-3991

Supera Stent for Peripheral Arterial Disease: Scoping Review with ☸️SAIMSARA.

Cardiac & Vascular Health

Issue 1, Volume 1, 2026

Chat with this issue

DOI: 10.62487/saimsara32125f88

Editorial note

• Last update: 2026-05-29 21:27:31

What is this paper about

Supera is not just another femoropopliteal stent story: the evidence shows a device whose success depends heavily on deployment precision, vessel preparation, lesion mechanics, and anatomical stress. The full review separates durable patency signals from real-world failure zones, including elongation, fracture, popliteal stress, dialysis-access uncertainty, and off-label use beyond the core femoropopliteal indication.

Human-verified editorial review Verified by World ID proof-of-human. This editorial layer was submitted from a SAIMSARA account verified as a unique human.

Abstract: To systematically scope and synthesize the clinical outcomes, mechanical performance, procedural techniques, and complication profiles of the Supera interwoven nitinol stent in peripheral vascular interventions. The review uses 79 references and builds its evidence map from 77 original studies with 6003 total participants/sample observations (topic-deduplicated ΣN). This scoping review suggests that the Supera interwoven nitinol stent supports durable patency across complex peripheral arterial territories, with an unweighted median 12-month primary patency of approximately 81% spanning common femoral, superficial femoral, and popliteal segments. The dominant signal indicates that outcomes are shaped less by the device itself than by lesion complexity, deployment quality, and anatomical context, with compressed deployment and IVUS guidance associated with improved patency and stent fracture clustered around extreme mechanical stress zones. Evidence in non-femoropopliteal and dialysis access applications remains sparse and largely case-based, limiting firm recommendations beyond core indications. Future randomized trials with standardized endpoints and extended follow-up are needed to clarify the long-term value of adjunctive strategies and to define the boundaries of Supera applicability in high-stress and off-label anatomies.

Keywords: Supera stent; Femoropopliteal occlusive disease; Popliteal artery aneurysm; Endovascular therapy; Stent fracture; Primary patency; Peripheral arterial disease; Superficial femoral artery; Nitinol stent; Common femoral artery

Review Stats

Final search date and database lock: 2026-05-20 21:49:22 CEST
Plan: Pro (expanded craft tokens; source: Semantic Scholar)
Source: Semantic Scholar
Total Abstracts/Papers: 265988
Downloaded Abstracts/Papers: 1000
Included original and non-original Abstracts/Papers (all): 91
Included original Abstracts/Papers (Vote counting by direction of effect): 77
Reference Index (links used in paper): 79
Total participants/sample observations (topic deduplicated ΣN): 6003

Get access to the full paper

Unlock the full evidence map

Full paper access includes the complete human-readable review, figures, reference index, PDF export, and machine-readable Evidence JSON download.
Evidence JSON can also be purchased separately if you only need the LLM-ready object for agent, AI, or RAG workflows.
Institutional or library access? Sign in with your institution email to open all available SAIMSARA papers under your institution access arrangement.
Need a SAIMSARA review on your own topic? ☸️Request.

Reference Index (79)

[1] Endovascular Treatment of Femoro-Popliteal Disease with the Supera Stent: A Single Center Experience — https://doi.org/10.3390/jcm14051704
[2] Early Supera stent fracture after treatment of popliteal artery occlusion caused by artificial knee joint: a case report — https://doi.org/10.1093/ehjcr/ytaf114
[3] Repeated Supera stent fracture following stenting for popliteal artery occlusion: a case report — https://doi.org/10.1177/03000605241308488
[4] Revisiting the gold standard: Supera stent performance in common femoral artery lesions, medium- to long-term results. — https://doi.org/10.1016/j.avsg.2025.07.015
[5] Repair of migration and excessive kinking of the Viabahn stent graft with Supera stent relining in the popliteal artery aneurysm — https://doi.org/10.1016/j.jvscit.2025.101952
[6] Efficacy of Supera Stent in the Treatment of Complex Femoropopliteal Artery Lesions: A Short-Term Result Analysis of Real-World Evidence. — https://doi.org/10.1016/j.avsg.2024.06.022
[7] Three-Year Real-World Outcomes of Interwoven Nitinol Supera Stent Implantation in Long and Complex Femoropopliteal Lesions — https://doi.org/10.3390/jcm12144869
[8] Midterm Results of the Supera Stent for the Treatment of Femoropopliteal Occlusive Disease. — https://doi.org/10.1016/j.avsg.2022.05.031

Unlock the full paper to view the complete Reference Index.